Stories
Cohance Lifesciences Appoints Abhimanyu Ojha as New Chief Financial Officer
N
News18•12-10-2026, 20:00
Cohance Lifesciences Appoints Abhimanyu Ojha as New Chief Financial Officer
- •Abhimanyu Ojha has been appointed as the Chief Financial Officer of Cohance Lifesciences effective Monday.
- •He brings over two decades of extensive finance leadership experience in multinational healthcare and pharmaceutical companies.
- •Ojha previously served as Global CFO and President of Finance at Intas Pharmaceuticals.
- •His career includes senior leadership roles at major firms such as Viatris, Mylan, Sun Pharmaceuticals, and Ranbaxy Laboratories.
- •Cohance Lifesciences operates as an innovator-focused global contract research, development, and manufacturing organization.
Key Questions Answered
Cohance Lifesciences announced the appointment of Abhimanyu Ojha as its new Chief Financial Officer, effective Monday.
Ojha brings over two decades of finance leadership experience across multinational healthcare and pharmaceutical firms. Most recently, he served as Global CFO and President, Finance at Intas Pharmaceuticals, and previously held senior roles at Viatris, Mylan, Sun Pharmaceuticals, and Ranbaxy Laboratories.
Cohance Lifesciences was formerly known as Suven Pharmaceuticals, operating as an innovator-focused global contract research, development, and manufacturing organisation formed via a merger.
